FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 113 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 469.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $265,000 | +48.9% | 56,422 | -28.2% | 0.04% | -2.2% |
Q1 2020 | $178,000 | -61.6% | 78,534 | -22.1% | 0.04% | -16.7% |
Q4 2019 | $463,000 | +332.7% | 100,876 | +265.1% | 0.05% | +285.7% |
Q3 2019 | $107,000 | -10.1% | 27,626 | +39.8% | 0.01% | +7.7% |
Q2 2019 | $119,000 | -72.1% | 19,767 | -35.4% | 0.01% | -45.8% |
Q3 2018 | $426,000 | -26.7% | 30,600 | -9.5% | 0.02% | -22.6% |
Q1 2018 | $581,000 | -29.8% | 33,800 | +22.9% | 0.03% | -42.6% |
Q2 2017 | $828,000 | -48.1% | 27,500 | -37.6% | 0.05% | -37.2% |
Q1 2017 | $1,594,000 | -56.0% | 44,100 | -39.0% | 0.09% | -60.4% |
Q4 2016 | $3,622,000 | -2.8% | 72,279 | +1.8% | 0.22% | +8.5% |
Q3 2016 | $3,727,000 | -4.5% | 71,000 | -24.8% | 0.20% | -7.4% |
Q2 2016 | $3,904,000 | +5.7% | 94,425 | +3.9% | 0.22% | -8.1% |
Q1 2016 | $3,692,000 | +23.2% | 90,862 | +25.8% | 0.24% | +59.9% |
Q4 2015 | $2,996,000 | +199.0% | 72,200 | +10.9% | 0.15% | +200.0% |
Q3 2015 | $1,002,000 | +235.1% | 65,114 | +441.3% | 0.05% | +345.5% |
Q2 2015 | $299,000 | -66.4% | 12,029 | -69.1% | 0.01% | -68.6% |
Q1 2015 | $889,000 | – | 38,896 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eventide Asset Management | 601,000 | $24,587,000 | 1.39% |
HealthCor Management, L.P. | 1,010,930 | $41,357,000 | 1.39% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 86,500 | $3,535,000 | 1.38% |
PURA VIDA INVESTMENTS, LLC | 75,000 | $3,068,000 | 0.90% |
BB BIOTECH AG | 777,500 | $31,808,000 | 0.88% |
AWM Investment Company, Inc. | 100,000 | $4,091,000 | 0.71% |
Granite Point Capital Management, L.P. | 50,000 | $2,046,000 | 0.43% |
Rock Springs Capital Management LP | 217,700 | $8,906,000 | 0.41% |
Crestline Management, LP | 50,919 | $2,083,000 | 0.29% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,432,700 | $99,522,000 | 0.24% |